remdesivir | Page 2 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
January 28, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JANUARY 28, 2026

remdesivir

remdesivir

Remdesivir pushes up Beacon Pharma’s profit  

Remdesivir pushes up Beacon Pharma’s profit  

At the end of the first half of this fiscal year, the company’s earnings per share stood at Tk1.26.

antiviral drug Remdesivir. Photo : BSS/AFP

Single-patient study adds to debate over Gilead's remdesivir for Covid-19

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

US infectious disease group backs Gilead's remdesivir for Covid-19 treatment

Hasty drug approval doesn’t always work out. Photographer: OLIVIER DOULIERY/AFP via Getty Images/Bloomberg

Remdesivir’s failure is a warning for Covid-19 vaccines

Photo: Collected.

Remdesivir: Don't use drug Trump took for Covid-19, WHO says

WHO says it will have advice on Remdesivir in 3-4 weeks

WHO says it will have advice on Remdesivir in 3-4 weeks

antiviral drug Remdesivir. Photo : BSS/AFP

US gives full approval to antiviral remdesivir to treat Covid-19

Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. Photo: Reuters

Remdesivir has ‘little effect’ on Covid-19 death risks, WHO study says

European Union flags fly outside the EU Commission headquarters in Brussels, Belgium September 19, 2019/ Reuters

EU signs joint procurement contract for remdesivir supply

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Europe in remdesivir crisis

President Donald Trump wears a mask as he tours the American Red Cross national headquarters in Washington on July 30.Doug Mills / The New York Times via AP pool

What medicines Trump is given for Covid-19 treatment

Photo: Collected.

Beximco Pharma, IFIC Bank, Nepal Bangladesh Bank donate Remdesivir to Nepal

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

India's shortage of remdesivir is easing, says producer Cipla

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net